Meyka Pro banner
Waverunner Capital Inc.

Waverunner Capital Inc. Fundamental Analysis (CNQ: CHM.CN)

CHM.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.05
$0.05(900.00%)
Canadian Market is Open · 14:35

Waverunner Capital Inc. Fundamental Analysis (CNQ: CHM.CN)

Waverunner Capital Inc. (CNQ: CHM.CN) shows weak financial fundamentals with a PE ratio of -0.07, profit margin of 0.00%, and ROE of 1.16%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position65.73%
PEG Ratio0.00

Areas of Concern

ROE1.16%
Operating Margin0.00%
Current Ratio0.72
We analyze CHM.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 74.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
74.7/100

We analyze CHM.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CHM.CN struggles to generate sufficient returns from assets.

ROA > 10%
-8.68%

Valuation Score

Excellent

CHM.CN trades at attractive valuation levels.

PE < 25
-0.07
PEG Ratio < 2
0.00

Growth Score

Weak

CHM.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CHM.CN shows balanced financial health with some risks.

Debt/Equity < 1
-1.63
Current Ratio > 1
0.72

Profitability Score

Weak

CHM.CN struggles to sustain strong margins.

ROE > 15%
115.90%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is CHM.CN Expensive or Cheap?

P/E Ratio

CHM.CN trades at -0.07 times earnings. This suggests potential undervaluation.

-0.07

PEG Ratio

When adjusting for growth, CHM.CN's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Waverunner Capital Inc. at -1.14 times its book value. This may indicate undervaluation.

-1.14

EV/EBITDA

Enterprise value stands at 0.00 times EBITDA. This is generally considered low.

0.00

How Well Does CHM.CN Make Money?

Net Profit Margin

For every $100 in sales, Waverunner Capital Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $1.16 in profit for every $100 of shareholder equity.

1.16%

ROA

Waverunner Capital Inc. generates $-8.68 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.68%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.07 in free cash annually.

$-0.07

FCF Yield

CHM.CN converts -1.13% of its market value into free cash.

-1.13%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.07

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.14

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.63

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.16

vs 25 benchmark

ROA

Return on assets percentage

-8.68

vs 25 benchmark

ROCE

Return on capital employed

-3.66

vs 25 benchmark

How CHM.CN Stacks Against Its Sector Peers

MetricCHM.CN ValueSector AveragePerformance
P/E Ratio-0.0732.02 Better (Cheaper)
ROE115.90%569.00% Weak
Net Margin0.00%29961.00% Weak
Debt/Equity-1.630.53 Strong (Low Leverage)
Current Ratio0.725.67 Weak Liquidity
ROA-868.28%-96.00% (disorted) Weak

CHM.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Waverunner Capital Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ